Production (Stage)
Harmony Biosciences Holdings, Inc.
HRMY
$35.85
$0.431.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -8.21% | 8.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.21% | 8.19% | |||
| Cost of Revenue | -41.20% | 27.19% | |||
| Gross Profit | 4.00% | 2.51% | |||
| SG&A Expenses | 9.72% | 0.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.72% | 17.06% | |||
| Operating Income | 0.93% | -9.70% | |||
| Income Before Tax | 1.82% | -9.68% | |||
| Income Tax Expenses | 73.91% | -58.45% | |||
| Earnings from Continuing Operations | -7.91% | 7.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.91% | 7.34% | |||
| EBIT | 0.93% | -9.70% | |||
| EBITDA | 0.84% | -8.84% | |||
| EPS Basic | -8.25% | 6.91% | |||
| Normalized Basic EPS | 1.45% | -10.03% | |||
| EPS Diluted | -8.04% | 7.37% | |||
| Normalized Diluted EPS | 1.28% | -9.84% | |||
| Average Basic Shares Outstanding | 0.37% | 0.40% | |||
| Average Diluted Shares Outstanding | 0.53% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||